GlassScriptPhysician profile
Natasha Bing
NPI 1033751672
$1,658.06
in general payments reported to CMS, 2019-2025
22 companies · $995 in 2025
The $995 reported for 2025 was more than what 85% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $166 · 2022: $87.30 · 2023: $124 · 2024: $286 · 2025: $995.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,332 · Education: $72.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,332.38 |
| Education | $72.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $255.17 | 2024-2025 | Erleada, Akeega |
| Endo USA, INC. | $247.77 | 2024-2025 | Xiaflex, Aveed |
| Axonics, INC. | $204.81 | 2021-2023 | Axonics |
| Sumitomo Pharma America, INC. | $160.52 | 2024-2025 | Gemtesa |
| Astellas Pharma US INC | $152.01 | 2021-2025 | Xtandi, Myrbetriq |
| C. R. Bard, INC. & Subsidiaries | $137.84 | 2025 | |
| Dexcom, INC. | $66.96 | 2025 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $66.08 | 2024-2025 | Spaceoar Vue System - 10ml, Axonics |
| Dendreon Pharmaceuticals LLC | $61.70 | 2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $46.04 | 2025 | |
| Abbvie INC. | $38.63 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $34.10 | 2025 | Prolaris |
| Novartis Pharmaceuticals Corporation | $27.26 | 2025 | |
| Halozyme INC | $21.51 | 2023 | |
| Merck Sharp & Dohme LLC | $20.95 | 2025 | Keytruda, Keytruda Qlex |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $20.66 | 2025 | |
| Novo Nordisk INC | $18.19 | 2025 | |
| Clarus Therapeutics INC. | $17.22 | 2021 | |
| Olympus America INC. | $16.05 | 2025 | Itind System |
| Tolmar Pharmaceuticals, INC. | $15.22 | 2022 | |
| Exact Sciences Corporation | $14.80 | 2025 | Cologuard Collection Kit |
| Amgen INC. | $14.57 | 2024 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natasha Bing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.